Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 1/20 | 0.40 |
| ▸ | ELOC | Q15369 | 1/20 | 0.40 |
| ▸ | ELOB | Q15370 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
| ▸ | TGM2 | P21980 | 1/20 | 0.30 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.30 |
| ▸ | TUBB | P07437 | 1/20 | 0.30 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.30 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.30 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL86831 | 0.84 | MEN1 (0.41) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL13871480 | 0.82 | GSK3B (0.39) | HPGDGSK3BKDM4ENPC1 | |
| SCHEMBL85980 | 0.82 | VHL (0.35) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL85777 | 0.80 | KMT2A (0.40) | VHLELOCELOBHPGDKDM4E | |
| SCHEMBL84260 | 0.80 | VHL (0.46) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL84470 | 0.79 | VHL (0.33) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL87396 | 0.79 | VHL (0.36) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL87186 | 0.78 | VHL (0.38) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL87130 | 0.72 | VHL (0.37) | VHLELOCELOBHPGDL3MBTL1 | |
| SCHEMBL67751 | 0.69 | KDM4E (0.54) | VHLELOCELOBHPGDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2053095-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2017-02-22 | — | — | EP | disclosed |
| EP-2053095-B1 | Ink composition and inkjet recording method using the same | FUJIFILM CORP (JP) | 2014-03-26 | — | — | EP | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-8129447-B2 | Ink composition and inkjet recording method using the same | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| EP-2053095-A2 | Ink composition and inkjet recording method using the same | Fujifilm Corporation (JP) | 2009-04-29 | — | — | EP | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090087575-A1 | INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME | RB1, IK, NOX1 | VHL 3930/4885ELOC 3228/4885ELOB 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.